To characterize cell-type specific patterns of RBM45 pathology in ALS, FTLD-TDP, and AD, we quantified RBM45 nuclear and cytoplasmic pathology across these diseases and measured the co-localization of the NSB marker protein SAFB with RBM45 nuclear inclusions. The gene discussed is SAFB; the disease is Alzheimer disease.